Đăng xuất
Check the state of the eardrum before any prescription.
This product contains oxytetracycline, a cycline antibiotic, which, after administration by the systemic route, is known for its toxicity to the teeth of children aged less than 8 years and for the risk of photosensitisation.
In the absence of data on the medicine administered in auricular powder or suspension form, these risks cannot be totally ruled out but are undoubtedly minimal given the quantity administered; the penetration of oxytetracycline into the systemic circulation is even more unlikely when the medicinal product is administered in powder form.
Local administration of antibiotics contributes to sensitisation to the active substances with, potentially, systemic reactions.
The presence of a corticosteroid does not prevent the manifestations of allergy to the antibiotic, but may modify their clinical presentation.
Discontinue treatment as of the first signs of emergence of skin rash or any other sign of local or systemic hypersensitivity.
The attention of sportsmen is drawn to the fact that this product contains an active substance (dexamethasone) which may lead to a positive reaction in tests carried out in the context of anti-doping controls.
The persistence of a deposit of brownish powder in the external auditory canal may necessitate cleaning.
Special attention is to be paid to patients with a hearing aid; indeed, the persistence of the deposit may interfere with hearing-aid operation.
Do not inject, do not swallow.
At the time of use, avoid contact between the nozzle and the ear or fingers in order to limit the risks of contamination.
It is advisable to not combine this medicine with another local treatment.
If, after 10 days, or after 15 days in the event of otomycosis, symptoms persist, the patient is to return for reevaluation of the disease and treatment.
Effects on ability to drive and use machines: Not applicable.
